Sumatriptan succinate and Haemoglobin decreased - a phase IV clinical study of FDA data
Summary:
Haemoglobin decreased is reported as a side effect among people who take Sumatriptan succinate (sumatriptan succinate), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Atenolol, and have Bipolar disorder.
The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Sumatriptan succinate. It is created by eHealthMe based on reports of 9,380 people who have side effects when taking Sumatriptan succinate from the FDA, and is updated regularly.
What is Sumatriptan succinate?
Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.
What is Haemoglobin decreased?
Haemoglobin decreased is found to be associated with 2,395 drugs and 3,138 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
9,380 people reported to have side effects when taking Sumatriptan succinate.
Among them, 36 people (0.38%) have Haemoglobin decreased.

Among these 36 people:
How long have people been on Sumatriptan succinate when they have Haemoglobin decreased? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 100 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Haemoglobin decreased when taking Sumatriptan succinate? *
- female: 77.78 %
- male: 22.22 %
What is the age of people who have Haemoglobin decreased when taking Sumatriptan succinate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 3.57 %
- 30-39: 3.57 %
- 40-49: 35.71 %
- 50-59: 25.0 %
- 60+: 32.14 %
What are other drugs people take besides Sumatriptan succinate? *
- Atenolol: 11 people, 30.56%
- Vicodin: 10 people, 27.78%
- Clonazepam: 8 people, 22.22%
- Pravastatin Sodium: 7 people, 19.44%
- Neurontin: 7 people, 19.44%
- Naproxen: 7 people, 19.44%
- Warfarin Sodium: 7 people, 19.44%
- Meloxicam: 7 people, 19.44%
- Zolpidem Tartrate: 6 people, 16.67%
- Methocarbamol: 6 people, 16.67%
What are other side effects people have besides Haemoglobin decreased? *
- Haematocrit Decreased: 15 people, 41.67%
- Stress And Anxiety: 11 people, 30.56%
- Hypotension (abnormally low blood pressure): 10 people, 27.78%
- Depression: 10 people, 27.78%
- Pulmonary Embolism (blockage of the main artery of the lung): 10 people, 27.78%
- Insomnia (sleeplessness): 9 people, 25.00%
- Pneumonia: 9 people, 25.00%
- Suicide Attempt: 8 people, 22.22%
- Constipation: 8 people, 22.22%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 19.44%
What are the existing conditions these people have? *
- Bipolar Disorder (mood disorder): 7 people, 19.44%
- Birth Control: 5 people, 13.89%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 8.33%
- Asthma: 3 people, 8.33%
- Hypersensitivity: 3 people, 8.33%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 5.56%
- Multiple Myeloma (cancer of the plasma cells): 2 people, 5.56%
- Insomnia (sleeplessness): 2 people, 5.56%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.78%
- Nausea (feeling of having an urge to vomit): 1 person, 2.78%
* Approximation only. Some reports may have incomplete information.
Do you take Sumatriptan succinate and have Haemoglobin decreased?
- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sumatriptan succinate:
- Sumatriptan succinate (9,731 reports)
Haemoglobin decreased treatments and more:
- Haemoglobin decreased (141,785 reports)
How severe was Haemoglobin decreased and when was it recovered:
Expand to all the drugs that have ingredients of sumatriptan succinate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sumatriptan succinate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Haemoglobin decreased:
- Haemoglobin decreased (2,395 drugs)
Browse all the conditions that are associated with Haemoglobin decreased:
- Haemoglobin decreased (3,138 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan succinate) and Sumatriptan succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Triglide vs. Pravastatin Sodium, side effect and effectiveness comparison - 2 seconds ago
- Could Capecitabine cause Anger? - 13 seconds ago
- Could Memantine Hydrochloride cause Mental Status Changes? - 24 seconds ago
- Could Methylprednisolone cause Idiopathic Thrombocytopenic Purpura? - 27 seconds ago
- Could Alendronate Sodium cause Melanosis Coli? - 29 seconds ago
- Could Aldactone cause Peptic Ulcer Aggravated? - 34 seconds ago
- Could Methylprednisolone Sodium Succinate cause Mean Platelet Volume Decreased? - 41 seconds ago
- Could Effexor cause Joint Instability? - 44 seconds ago
- Could Effexor cause Injection Site Haemorrhage? - 45 seconds ago
- Could Methotrexate cause Tachyphrenia? - 58 seconds ago